Article

bizjournals.com on 2021-08-04 20:29

Biogen, Eisai to push for fast FDA approval for second Alzheimer's drug

Related news

WAlzheimer's drug from Biogen, partner receives FDA approval wraltechwire.com
Cambridge , Japan
FDA calls for investigation of Biogen Alzheimer's drug approval bizjournals.com
MFDA Approves Biogen, Eisai Remedy Lecanemab mvtelegraph.com
Chicago , Japan
Biogen And Eisai Present Positive Results For Experimental Alzheimer's Drug Forbes
BA Third Expert Quits FDA Panel Over Approval of Biogen Alzheimer's Drug 2 min barrons.com
MBiogen says it will pursue FDA approval of early Alzheimer's drug marketwatch.com
MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decision marketwatch.com
Japan , Switzerland , Canada , Brazil , Australia
BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min read barrons.com
Japan
MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min read marketwatch.com
Switzerland , Canton of Solothurn , Japan , San Francisco
Biogen, Eisai halt work on second of 3 clinical-stage Alzheimer's drugs bizjournals.com
Biogen And Eisai Say Alzheimer's Drug A Success, Reversing Earlier Result Forbes
BBiogen Stock Jumps on FDA Approval barrons.com
Wall Street , Mount Sinai , Unmet
Eisai and Biogen apply for approval of Alzheimer’s drug in Japan The Japan Times
Japan
Breakthrough Alzheimer's drug earns accelerated FDA approval New York Post
Biogen shares soar as FDA reviewers support Alzheimer's drug Sydney Morning Herald
Wall Street , Massachusetts , Cambridge
BFDA Approves Eisai and Biogen's New Alzheimer's Therapy 1 min read barrons.com
FDA seeks inquiry on Alzheimer's drug approval Arkansas Online
Brigham City
Biogen's Alzheimer's drug wins FDA approval bizjournals.com